Crystallization and preliminary X-ray analysis of the NADPH-dependent 3-quinuclidinone reductase from Rhodotorula rubra

(R)‐3‐Quinuclidinol is a useful compound that is applicable to the synthesis of various pharmaceuticals. The NADPH‐dependent carbonyl reductase 3‐quinuclidinone reductase from Rhodotorula rubra catalyzes the stereospecific reduction of 3‐quinuclidinone to (R)‐3‐quinuclidinol and is expected to be ut...

Full description

Saved in:
Bibliographic Details
Published inActa crystallographica. Section F, Structural biology and crystallization communications Vol. 65; no. 6; pp. 645 - 647
Main Authors Takeshita, Daijiro, Kataoka, Michihiko, Miyakawa, Takuya, Miyazono, Ken-ichi, Uzura, Atsuko, Nagata, Koji, Shimizu, Sakayu, Tanokura, Masaru
Format Journal Article
LanguageEnglish
Published 5 Abbey Square, Chester, Cheshire CH1 2HU, England International Union of Crystallography 01.06.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:(R)‐3‐Quinuclidinol is a useful compound that is applicable to the synthesis of various pharmaceuticals. The NADPH‐dependent carbonyl reductase 3‐quinuclidinone reductase from Rhodotorula rubra catalyzes the stereospecific reduction of 3‐quinuclidinone to (R)‐3‐quinuclidinol and is expected to be utilized in industrial production of this alcohol. 3‐Quinuclidinone reductase from R. rubra was expressed in Escherichia coli and purified using Ni‐affinity and ion‐exchange column chromatography. Crystals of the protein were obtained by the sitting‐drop vapour‐diffusion method using PEG 8000 as the precipitant. The crystals belonged to space group P41212, with unit‐cell parameters a = b = 91.3, c = 265.4 Å, and diffracted X‐rays to 2.2 Å resolution. The asymmetric unit contained four molecules of the protein and the solvent content was 48.4%.
Bibliography:ArticleID:AYF2NJ5033
ark:/67375/WNG-239NZ54X-8
istex:ED45BEF248F04C7A6AFE3BC9622DF0E9501EC0A8
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1744-3091
1744-3091
DOI:10.1107/S1744309109017588